Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Testing a Spanish Version of a Patient Toxicity Questionnaire
- Status
- COMPLETED
- Phase
- N/A
Salvage Therapy With High Dose Oral Clarithromycin in Relapsed or Refractory Extranodal Marginal Zone Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Biomarkers in Tissue Samples From Patients With Hodgkin Lymphoma Enrolled on ECOG-2496 Clinical Trial
- Status
- COMPLETED
- Phase
- N/A
Phase I Study of CS-7017 and Bexarotene
- Status
- TERMINATED
- Phase
- PHASE1
Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood
- Status
- COMPLETED
- Phase
- PHASE1
Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the HSP90 Inhibitor AUY922
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Longitudinal Survey Analysis in Lymphoma Survivors
- Status
- COMPLETED
- Phase
- N/A
EBUS-TBNA Versus EBUS-TBNB
- Status
- WITHDRAWN
- Phase
- NA
Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
- Status
- RECRUITING
- Phase
- N/A
In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1